MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.
about
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseasesAberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomaSignaling of miRNAs-FOXM1 in cancer and potential targeted therapyThe miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and diseaseLinkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?Epigenetic regulation of thyroid hormone receptor beta in renal cancer.Metabolic profiling reveals key metabolic features of renal cell carcinoma.Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.The VHL-dependent regulation of microRNAs in renal cancer.MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer.Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cellsExpression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinomaMicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cellsIdentification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencingReference miRNAs for miRNAome analysis of urothelial carcinomas.MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis.A new algorithm for integrated analysis of miRNA-mRNA interactions based on individual classification reveals insights into bladder cancer.Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.Signaling pathways in renal cell carcinoma.Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidneyRegulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma.Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites.MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAsmiRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas.miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1Epigenetics of kidney cancer and bladder cancer.Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5pThe potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.MiR-34b is associated with clinical outcome in triple-negative breast cancer patientsMiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.
P2860
Q24608620-909DA58E-C949-4790-A021-5B4E46FEEDA6Q24627680-CDD15957-0E10-4989-9F0E-8CF3F59C1CDDQ26825764-1A961B0E-313F-4F34-97CA-355A0B6C664FQ27015587-C1FB54DD-260B-41A7-AD7D-1F3D5185A163Q30318519-F949D9D8-7E4E-4C48-9CE6-FAE795EDD787Q31161553-33E9BA67-4379-4529-AAD6-3ED3BA778EDAQ33511655-EEB4BF28-C638-42E9-8821-5A3921340848Q33565049-06ED6FD3-3F41-4E71-820E-7F48E249E46EQ33694120-0472BFE3-525A-473A-B75C-2C1653CC6C7AQ33724729-632C1166-2705-4217-9EFA-072EE27BCB42Q33724744-09B5E489-76BF-4CA4-A844-637C467756B4Q33799049-C1151ABC-9EAC-48E1-9BD4-0280D4D15531Q33873336-677AC120-71BD-448B-BAC8-A0A3794A72E5Q34008638-8F354033-5402-4B4E-B384-E1AE3B88B7E1Q34017947-B3B15072-AEE4-4F1E-9DA2-1C669B750C0DQ34045027-23838D74-5AA3-48EC-AABF-7C401411A9DFQ34152578-EE87B528-CB8F-4264-A365-5951FBC5DFF7Q34209054-615A848B-6F6B-4C28-AA62-E2544AFC32FDQ34279691-7DECB54B-2DB3-4614-BDA1-3A6C28CA0582Q34321089-E3E734B5-E321-475B-8AFE-E3B4E9B36FAFQ34321313-EC2FB723-CE83-44AF-9364-0DD6C79A92A2Q34412920-19A418E1-50F8-4184-A033-E8A9F441EC4AQ34745995-A3EE6B0C-B17E-4FC2-A64D-08D4EA1F53F3Q34796840-10A8DED3-8649-4401-9CE6-BDE436FD581AQ34978827-F32307F3-EEDF-419A-9296-3DF5EBF0CACAQ35096116-68A5D9E6-DCAC-4154-8A67-CEA515104111Q35118634-8DA46134-DE7C-487B-AABF-84C21EE5B032Q35479824-D4D9E4F3-46CC-4D93-88A2-257C8FB66B6FQ35496606-2591FBD3-F715-4EC0-B42F-F7EA4EC67A22Q35582977-9B8BEC07-939F-4D17-B747-511AD8799B72Q35621551-1B8ED92C-0D4C-4A78-8D3F-E05ACC26CA88Q35623283-98A41EB7-9420-4D4E-A792-C354BD4CF4E6Q35678368-D5C45343-1EAA-413A-B326-06B9F406CA1CQ35741847-0A57A81F-9925-477D-AE72-E7E22A5C4E55Q35828624-E5C5461B-96B6-458D-9A6A-A6C102984869Q35857807-3FF81565-1754-4C40-8264-499E11E91F8DQ35918018-2EF418B9-882B-4BA9-B863-06F6DA49DA05Q35919291-0A1AAA99-C660-483E-84FA-E447DD02B381Q35950656-9C42F4C4-7E34-4814-B532-8EACA6503894Q35955250-860DC5C3-E75C-445E-808B-74CA9518213F
P2860
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
MicroRNA profiling of clear ce ...... re to define renal malignancy.
@ast
MicroRNA profiling of clear ce ...... re to define renal malignancy.
@en
type
label
MicroRNA profiling of clear ce ...... re to define renal malignancy.
@ast
MicroRNA profiling of clear ce ...... re to define renal malignancy.
@en
prefLabel
MicroRNA profiling of clear ce ...... re to define renal malignancy.
@ast
MicroRNA profiling of clear ce ...... re to define renal malignancy.
@en
P2093
P2860
P50
P1476
MicroRNA profiling of clear ce ...... re to define renal malignancy.
@en
P2093
Carsten Stephan
Glen Kristiansen
Ina Wagner
Manfred Johannsen
Marco Albrecht
Monika Jung
Thomas Rudel
Tobias Waller
Wilfried Nietfeld
P2860
P304
P356
10.1111/J.1582-4934.2009.00705.X
P577
2009-02-17T00:00:00Z